Ms Pero will lead the expansion of the Global Alliance for TB Drug Development’s (TB Alliance) staff and internal operations as it advances the new tuberculosis (TB) drug pipeline in history.
Ms Pero was most recently senior vice president of corporate administration for Endo Pharmaceuticals.
Jerome Premmereur, president and CEO of TB Alliance, said: “Colleen brings strong leadership to the TB Alliance and experience to build and sustain the capabilities we need to achieve our urgent mission.”